ImmunityBio, Inc. (IBRX)

ImmunityBio Stock Forecast

Stock Price Forecast

According to 5 professional analysts, the 12-month price target for ImmunityBio stock ranges from a low of $5.00 to a high of $30. The average analyst price target of $11.4 forecasts a 322.22% increase in the stock price over the next year.

Price Target: $11.40 (+322.22%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$11.4	$8.00	$30
Change	+85.19%	+322.22%	+196.30%	+1011.1%

Analyst Ratings

The average analyst rating for ImmunityBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	2	2	4	4	4	4
Buy	0	0	0	0	1	1
Hold	1	1	1	1	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	5	5	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+196.30%	Jun 4, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,011.11%	Jun 3, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $30	Strong Buy	Maintains	$30	+1,011.11%	May 28, 2025
Joseph Catanzaro Piper Sandler	Piper Sandler	Hold → Buy Upgrades $4.25 → $5	Hold → Buy	Upgrades	$4.25 → $5	+85.19%	May 20, 2025
Andres Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+196.30%	May 12, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

98.49M

Increased by 567.98%

from 14.75M

Revenue Next Year

256.63M

Increased by 160.56%

from 98.49M

EPS This Year

-0.48

from -0.62

EPS Next Year

-0.32

from -0.48

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	605.00K	934.00K	240.00K	622.00K	14.75M	98.49M	256.63M	897.05M
Revenue Growth	-72.52%	54.38%	-74.30%	159.17%	2,270.58%	567.98%	160.56%	249.55%
EPS	-0.59	-0.89	-1.04	-1.15	-0.62	-0.48	-0.32	0.18
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	14.71
No. Analysts	-	-	-	-	-	7	7	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	130.2M	353.1M	1.3B
Avg	98.5M	256.6M	897.1M
Low	81.9M	174.1M	549.1M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	783.0%	258.5%	390.6%
Avg	568.0%	160.6%	249.5%
Low	455.1%	76.7%	114.0%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.45	-0.26	0.45
Avg	-0.48	-0.32	0.18
Low	-0.54	-0.46	-0.07

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.